Skip to content
Clinical Trials – home
Verifiedinfo

Skånes Universitetssjukhus Malmö

Sweden Jan Waldenströms gata 1B, 20502 Malmo, Sweden

  • 1 trial recruiting
  • Rheumatoid arthritis · Fibromyalgia · Arteriosclerosis
  • Adult patients

About Specializations

Skånes Universitetssjukhus Malmö in Malmo, Sweden specialises in clinical trials of conditions such as Rheumatoid arthritis, Fibromyalgia, Arteriosclerosis, Prostate cancer, and other specialisations. This site conducts important research.

Main research areas of the site

Prostate Cancer Research

The medical center is at the forefront of prostate cancer research, focusing on innovative treatment strategies for high-risk nonmetastatic cases. The ongoing studies aim to enhance the safety and effectiveness of therapeutic combinations, providing new hope for patients who have experienced progression after definitive therapy.

  • Combination Therapy
  • Monotherapy Efficacy
  • Comparative Effectiveness

By evaluating the efficacy of enzalutamide in combination with leuprolide, as well as as a standalone treatment, the center contributes significantly to the development of personalized treatment plans that could improve patient outcomes and quality of life.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Site location
Jan Waldenströms gata 1B20502 MalmoSweden
Recruiting now
1 trial
Conditions studied
4
Partner status
Verified

More sites in MalmoSweden

Recruiting now

Ongoing trials

Clinical trials currently enrolling participants at this site.

Condition
Type of trial
Recruitment status
Quick filters

4 clinical trials

Countries:SwedenSweden
  • Participants:18–64 years · 65+ years
  • Substances:Abatacept
  • Sponsor:Karolinska Institutet

Fibromyalgia

Not yet recruiting
Registered drugNo placebo
Countries:SwedenSweden
  • Participants:18–64 years
  • Substances:Methylprednisolone
  • Sponsor:Region Stockholm – SLSO

Arteriosclerosis

Not recruiting
Registered drug
Countries:SwedenSweden
  • Participants:18–64 years · 65+ years
  • Substances:Atorvastatin
  • Sponsor:Novartis Pharma AG

Prostate cancer

Not recruiting
Registered drug
Countries:SwedenSweden
  • Participants:18–64 years · 65+ years
  • Substances:Enzalutamide
  • Sponsor:Medivation Inc.
Is this your site?

Join our network of research sites

Move up to Verified & featured: your own description, photos and phone number on this page, and top placement on every trial you run.

See the offer for sites
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.